Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,753 | 418 | 99.5% |
| Gift | $45.00 | 1 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Shire North American Group Inc | $1,652 | 69 | $0 (2019) |
| Allergan, Inc. | $1,201 | 93 | $0 (2022) |
| Bausch & Lomb, a division of Bausch Health US, LLC | $1,140 | 29 | $0 (2021) |
| Oyster Point Pharma, Inc. | $893.03 | 31 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $749.39 | 32 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $741.70 | 45 | $0 (2023) |
| Bausch & Lomb Americas Inc. | $701.53 | 20 | $0 (2024) |
| Aerie Pharmaceuticals, Inc. | $471.01 | 18 | $0 (2021) |
| ABBVIE INC. | $437.17 | 20 | $0 (2024) |
| Kala Pharmaceuticals, Inc. | $360.18 | 17 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,568 | 54 | Bausch & Lomb Americas Inc. ($440.18) |
| 2023 | $993.81 | 39 | Oyster Point Pharma, Inc. ($334.92) |
| 2022 | $1,333 | 56 | Oyster Point Pharma, Inc. ($426.56) |
| 2021 | $968.17 | 57 | Kala Pharmaceuticals, Inc. ($252.11) |
| 2020 | $710.93 | 41 | Allergan, Inc. ($294.60) |
| 2019 | $1,277 | 53 | Bausch & Lomb, a division of Bausch Health US, LLC ($477.04) |
| 2018 | $1,756 | 67 | Shire North American Group Inc ($672.50) |
| 2017 | $1,192 | 52 | Shire North American Group Inc ($807.45) |
All Payment Transactions
419 individual payment records from CMS Open Payments — Page 1 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Harrow Eye, LLC | VEVYE (Drug) | Food and Beverage | In-kind items and services | $28.13 | General |
| Category: OPTOMETRY | ||||||
| 12/02/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $17.94 | General |
| Category: Ophthalmology | ||||||
| 11/19/2024 | Thea Pharma Inc. | IYUZEH (Drug) | Food and Beverage | In-kind items and services | $24.69 | General |
| Category: OPHTHALMOLOGY | ||||||
| 11/13/2024 | Bausch & Lomb Americas Inc. | VYZULTA (Drug) | Food and Beverage | In-kind items and services | $98.40 | General |
| Category: Ophthalmology | ||||||
| 11/11/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $23.82 | General |
| Category: Ophthalmology | ||||||
| 10/30/2024 | Alcon Vision LLC | Simbrinza (Drug) | Food and Beverage | In-kind items and services | $11.23 | General |
| Category: Ophthalmology | ||||||
| 10/29/2024 | Harrow Eye, LLC | VEVYE (Drug) | Food and Beverage | In-kind items and services | $18.41 | General |
| Category: OPTOMETRY | ||||||
| 10/23/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $13.61 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 10/21/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $19.03 | General |
| Category: Ophthalmology | ||||||
| 10/09/2024 | Alcon Vision LLC | Simbrinza (Drug) | Food and Beverage | In-kind items and services | $26.08 | General |
| Category: Ophthalmology | ||||||
| 10/09/2024 | Bausch & Lomb Americas Inc. | VYZULTA (Drug) | Food and Beverage | In-kind items and services | $11.87 | General |
| Category: Ophthalmology | ||||||
| 10/09/2024 | Bausch & Lomb Americas Inc. | VYZULTA (Drug) | Food and Beverage | In-kind items and services | $3.64 | General |
| Category: Ophthalmology | ||||||
| 09/25/2024 | Bausch & Lomb Americas Inc. | VYZULTA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Ophthalmology | ||||||
| 08/26/2024 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $16.48 | General |
| Category: Dry eyes | ||||||
| 08/19/2024 | Alcon Vision LLC | Rocklatan (Drug), Rhopressa, Simbrinza | Food and Beverage | In-kind items and services | $148.05 | General |
| Category: Ophthalmology | ||||||
| 08/19/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $23.38 | General |
| Category: Ophthalmology | ||||||
| 08/19/2024 | Bausch & Lomb Americas Inc. | DOCTORS ALLERGY FORMULA (Device) | Food and Beverage | In-kind items and services | $19.04 | General |
| Category: Ophthalmology | ||||||
| 08/14/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $14.88 | General |
| Category: EYE CARE | ||||||
| 08/05/2024 | Bausch & Lomb Americas Inc. | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: Ophthalmology | ||||||
| 07/29/2024 | Alcon Vision LLC | Simbrinza (Drug) | Food and Beverage | In-kind items and services | $25.63 | General |
| Category: Ophthalmology | ||||||
| 07/23/2024 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $9.80 | General |
| Category: Dry eyes | ||||||
| 07/08/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $28.83 | General |
| Category: Ophthalmology | ||||||
| 07/03/2024 | Bausch & Lomb Americas Inc. | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $8.58 | General |
| Category: Ophthalmology | ||||||
| 06/26/2024 | Harrow Eye, LLC | VEVYE (Drug) | Food and Beverage | In-kind items and services | $25.57 | General |
| Category: OPTOMETRY | ||||||
| 06/17/2024 | Alcon Vision LLC | Simbrinza (Drug) | Food and Beverage | In-kind items and services | $17.29 | General |
| Category: Ophthalmology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 647 | 765 | $172,305 | $49,222 |
| 2022 | 17 | 612 | 730 | $153,970 | $50,330 |
| 2021 | 13 | 496 | 606 | $155,810 | $66,233 |
| 2020 | 8 | 368 | 454 | $79,979 | $32,761 |
All Medicare Procedures & Services
54 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 68761 | Closure of tear duct opening using plug | Office | 2023 | 28 | 53 | $19,800 | $8,422 | 42.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 75 | 107 | $19,550 | $8,191 | 41.9% |
| 68040 | Removal of scars of eyelid lining due to infection | Office | 2023 | 58 | 76 | $30,000 | $5,166 | 17.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 42 | 48 | $11,500 | $5,037 | 43.8% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 34 | 34 | $8,700 | $3,837 | 44.1% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 72 | 74 | $18,100 | $3,805 | 21.0% |
| 92250 | Photography of the retina | Office | 2023 | 81 | 89 | $13,275 | $2,686 | 20.2% |
| 92273 | Measurement of retinal and optic nerve function | Office | 2023 | 20 | 22 | $5,420 | $2,581 | 47.6% |
| 92025 | Ct scan of cornea | Office | 2023 | 91 | 91 | $17,010 | $2,575 | 15.1% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 23 | 26 | $5,450 | $2,389 | 43.8% |
| 92286 | Imaging of front third of eye using a special microscope | Office | 2023 | 38 | 39 | $8,400 | $1,267 | 15.1% |
| 76512 | 2d ultrasound scan of eye tissue and structures | Office | 2023 | 15 | 28 | $4,100 | $1,130 | 27.6% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 17 | 19 | $2,940 | $716.57 | 24.4% |
| 92285 | Photography of content of eyes | Office | 2023 | 22 | 25 | $4,110 | $512.34 | 12.5% |
| 92133 | Imaging of optic nerve | Office | 2023 | 15 | 16 | $2,150 | $489.84 | 22.8% |
| 92020 | Exam of the internal drainage system of eye | Office | 2023 | 16 | 18 | $1,800 | $416.88 | 23.2% |
| 92012 | Established patient problem focused exam of visual system | Office | 2022 | 64 | 119 | $17,940 | $8,112 | 45.2% |
| 68761 | Closure of tear duct opening using plug | Office | 2022 | 23 | 44 | $17,200 | $6,511 | 37.9% |
| 92004 | New patient complete exam of visual system | Office | 2022 | 60 | 60 | $17,000 | $6,364 | 37.4% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 62 | 66 | $15,650 | $6,344 | 40.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 57 | 68 | $12,000 | $5,298 | 44.1% |
| 92083 | Exam of visual field with extended testing | Office | 2022 | 61 | 63 | $13,625 | $3,493 | 25.6% |
| 68040 | Removal of scars of eyelid lining due to infection | Office | 2022 | 32 | 44 | $17,400 | $2,903 | 16.7% |
| 92273 | Measurement of retinal and optic nerve function | Office | 2022 | 22 | 23 | $5,200 | $2,766 | 53.2% |
| 92250 | Photography of the retina | Office | 2022 | 48 | 49 | $7,325 | $1,512 | 20.6% |
About Dr. David Lee, MD
Dr. David Lee, MD is a Ophthalmology healthcare provider based in Flushing, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/06/2006. The National Provider Identifier (NPI) number assigned to this provider is 1003848714.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Lee, MD has received a total of $9,798 in payments from pharmaceutical and medical device companies, with $1,568 received in 2024. These payments were reported across 419 transactions from 25 companies. The most common payment nature is "Food and Beverage" ($9,753).
As a Medicare-enrolled provider, Lee has provided services to 2,123 Medicare beneficiaries, totaling 2,555 services with total Medicare billing of $198,546. Data is available for 4 years (2020–2023), covering 54 distinct procedure/service records.
Practice Information
- Specialty Ophthalmology
- Location Flushing, NY
- Active Since 07/06/2006
- Last Updated 07/08/2007
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1003848714
Products in Payments
- XIIDRA (Drug) $2,409
- TYRVAYA (Drug) $893.03
- VYZULTA (Drug) $820.34
- Cequa (Drug) $584.41
- LUMIGAN (Drug) $409.66
- INVELTYS (Drug) $360.18
- LOTEMAX SM (Drug) $336.13
- Rhopressa (Drug) $329.44
- Vemlidy (Drug) $250.00
- DURYSTA (Drug) $248.13
- COMBIGAN (Drug) $246.40
- RESTASIS (Drug) $200.42
- VEVYE (Drug) $192.61
- VUITY (Drug) $173.05
- ACTHAR (Biological) $169.95
- Simbrinza (Drug) $152.08
- XEN (Device) $149.11
- Rocklatan (Drug) $148.05
- MIEBO (Drug) $145.28
- ALREX (Drug) $120.01
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Flushing
Richard Najac, Md, MD
Ophthalmology — Payments: $144,483
Wilson Ko, M.d, M.D
Ophthalmology — Payments: $17,848
Dr. Sheldon Rabin, M.d, M.D
Ophthalmology — Payments: $5,944
Dr. Ted Du, M.d, M.D
Ophthalmology — Payments: $5,942
Dr. Willy Ky, M.d, M.D
Ophthalmology — Payments: $5,018
Tung Chu, Md, MD
Ophthalmology — Payments: $2,851